Serva Health

In this article, we break down how pharma hub services work and why they have become essential infrastructure for modern patient access programs. servahealth.com/patient-suppor… #PharmaHub #PatientAccess #SpecialtyPharmacy #Biopharma

Thank you to everyone who connected with the Serva Health team at ACCESS USA 2026. If we met at the conference, we appreciate the conversation, but if you didn't, we would welcome the opportunity to connect! #ACCESSUSA @InformaConnect

Clinical trial eligibility decisions often depend on one thing: accurate medical records. When the right records are obtained early it improves the overall efficiency of study enrollment. Read more: servahealth.com/patient-suppor… #medicalrecords #ClinicalResearch

Serva Health is heading to ACCESS USA 2026. ACCESS USA brings together leaders to discuss the future of patient access, affordability and support programs. If you are attending the conference in Philadelphia, stop by Booth #117 to connect #AccessUSA #AccessUSA2026 @InformaConnect

Global sales of rare disease drugs are projected to surpass $400 billion by 2032 and account for more than 21 percent of all prescription drug sales worldwide. fiercepharma.com/pharma/rare-di… #OrphanDrugs @FiercePharma

Clinical trials often ask a lot from participants. Complex visit schedules, travel, and unfamiliar procedures can make participation difficult, which contributes to trial dropout rates averaging around 25–30 percent. servahealth.com/patient-suppor… #ClinicalResearch #PatientRetention

Advances in genetic testing and diagnostics are helping researchers better understand tumor biology, identify drug targets, and guide more personalized treatment decisions for patients. @PharmaVoice pharmavoice.com/news/cancer-te…

Pharma hub services play a critical role in helping patients access specialty therapies, but many people only see part of the process. Read more on Pharma hub services: servahealth.com/patient-suppor… #PharmaHub #PatientAccess #PharmaceuticalIndustry #SpecialtyPharmacy #HealthcareAccess

Digital health technologies are changing how clinical trials collect data, support participants, and manage increasingly complex studies. servahealth.com/patient-suppor… #ClinicalTrials #DigitalHealth #ClinicalResearch #DecentralizedTrials #LifeSciences

Nurse-staffed patient engagement centers are transforming how pharmaceutical support programs contribute to therapy success. servahealth.com/patient-suppor… #PatientSupportPrograms #PharmaCommercialization #PatientEngagement #NurseNavigators #Biopharma #ServaHealth

Regulatory unpredictability in the vaccine space is raising questions about how consistent review expectations affect innovation, investment, and patient access. @PharmaVoice pharmavoice.com/news/vaccine-r… #ClinicalTrials #VaccineDevelopment #RegulatoryAffairs #Biopharma

Digital health technologies like eConsent, wearables, interoperable data standards, and AI-enabled tools are reshaping how clinical trials operate and how participants experience research. servahealth.com/patient-suppor… #ClinicalTrials #DigitalHealth #HealthTech #PatientExperience

Orphan drug economics are reshaping how biopharma companies source innovation, structure deals, and allocate capital in rare disease development. @PharmTechGroup pharmtech.com/view/rare-dise… #Biopharma #RareDisease #OrphanDrugs #ClinicalDevelopment

Claude now with a Clinicaltrials.gov integration. So cool!

Serva Health is headed to ACCESS USA 2026 at booth # 117 in Philadelphia, where leaders across the industry will come together to tackle current access, affordability, and operational challenges in the market access landscape. servahealth.com/patient-suppor… #accessusa #accessusa2026

Today we join the global community in recognizing Rare Disease Day, a day dedicated to raising awareness and generating support for the more than 300 million people worldwide living with a rare disease. @rarediseaseday #RareDiseaseDay #ShowYourStripes #RareDiseaseDay2026

Clinical trial retention is critical to study success, yet many research teams struggle with participant engagement and continuity. servahealth.com/patient-suppor… #ClinicalTrials #PatientEngagement

The FDA’s surprising rejection of Disc Medicine’s rare disease therapy bitopertin highlights growing questions around the Commissioner’s National Priority Voucher pilot program and what it truly delivers for sponsors and patients. biospace.com/fda/discs-fda-… #Biotech #FDA @biospace

🌍 The world is lighting up for Rare Disease Day! ✨ Visit a monument near you or light up your home to join the global chain of lights. 👉 Use our toolkits & event map to get started: go.rarediseaseday.org/LIGHTUP #LightUpForRare #RareDiseaseDay #ShareYourColours

Serva Health is proud to participate in Access USA 2026, engaging with healthcare leaders and innovators to advance patient engagement and elevate care delivery. We hope you come visit our Booth # 117! servahealth.com/patient-suppor… #AccessUSA #AccessUSA2026